Cardiovascular and Renal Drugs Advisory Committee Roster

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Chair
William R. Hiatt, M.D.
Expertise: Vascular Medicine
Term: 8/26/2003-6/30/2008
Professor of Medicine
University of Colorado
Colorado Prevention Center
789 Sherman Street, Suite 200
Denver, Colorado 80203

Designated Federal Officer
Cathy A. Miller, M.P.H., R.N.
Advisors and Consultants Staff HFD-21
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857
email: cathy.miller1@fda.hhs.gov
(301) 827-7001, FAX (301) 827-6776

Henry R. Black, M.D.
Expertise: Nephrology, Hypertension
Term: 10/31/2007-6/30/2011
Clinical Professor of Internal Medicine
Department of Internal Medicine
New York University School of Medicine
550 First Avenue
New York, New York 10016

* Steven D. Findlay, M.P.H.
Expertise: Health Policy Analyst
Term: 1/16/2006 - 6/30/2009
Consumers Union
1666 Connecticut Avenue, Suite 310
Washington, District of Columbia 20009

John M. Flack, M.D., M.P.H.
Expertise: Hypertension/Internal Medicine
Term: 1/16/2006 - 6/30/2009
Department of Medicine
University Health Center
Wayne State University
4201 St. Antoine, Suite 2E
Detroit, Michigan 48201

Frederick J. Kaskel, M.D., Ph.D.
Expertise: Pediatric Nephrology
Term: 12/3/2004 - 6/30/2008
Professor, Department of Pediatrics
Children's Hospital at Montefiore
Albert Einstein College of Medicine of Yeshiva University
111 East 210 Street
Bronx, New York 10467

Robert A. Harrington, M.D., F.A.C.C.
Expertise: Interventional Cardiology/ Cardiovascular Medicine
Term: 1/16/2006 - 6/30/2009
Professor of Medicine
Division of Cardiology,
Department of Medicine
Duke University Medical School
Duke Clinical Research Institute
2400 Pratt Street, NP 7007
Room 0311, Terrace Level
Durham, North Carolina 27705

Abraham Michael Lincoff, M.D., F.A.C.C.
Expertise: Interventional Cardiology/ Cardiovascular Medicine
Term: 1/16/2006 - 6/30/2009
Professor of Medicine
Department of Cardiovascular Medicine
The Cleveland Clinic Foundation
Desk F25, 9500 Euclid Avenue
Cleveland, Ohio 44195

James D. Neaton, Ph.D.
Expertise: Biostatistics
Term: 10/31/2007-6/30/2011
Professor of Biostatistics
Division of Biostatistics
Coordinating Centers for Biometric Research
University of Minnesota School of Public Health
2221 University Avenue S.E., Suite 200
Minneapolis, Minnesota 55414

Emil P. Paganini, M.D., F.A.C.P., F.R.C.P.
Expertise: Adult Nephrology
Term: 1/4/2007 - 6/30/2010
Critical Care Nephrology Consulting
10427 Mayfield Road
Chesterland, Ohio 44026

Lynn L. Warner Stevenson, M.D.
Expertise: Cardiomyopathy
Term: 12/3/2004 - 6/30/2008
Director, Cardiomyopathy Services
Brigham and Women's Hospital
Cardiovascular Division
75 Francis Street
Boston, Massachusetts 02115
John R. Teerlink, M.D.
Expertise: Heart Failure/Echocardiography
Term: 12/3/2004 - 6/30/2008
Director, Heart Failure Clinic
Director, Clinical Echocardiography Cardiology
University of California, San Francisco
San Francisco Veteran's Affairs Medical Center
111C, 4150 Clement Street
San Francisco, California 94121

*Consumer Representative
** Industry Representative (non voting)

PDF requires the free Adobe Acrobat Reader

Back to Top
Back to Cardiovascular and Renal Drugs Advisory Committee Info
Human Drug Advisory Committee Information

Updated: January 9, 2008